J Kevin Buchi insider trades: Ampio Pharmaceuticals (AMPE) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where J reports to the SEC
and 7 more companies
Open-market buys and sales
18 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 9, 2023 | AMPE | ↑ Buy | 21,858 | $0.29 | $6K | Direct | Jun 13, 2023 (4d) |
| Jun 8, 2023 | AMPE | ↑ Buy | 25,000 | $0.30 | $7K | Direct | Jun 9, 2023 (1d) |
| May 16, 2023 | AMPE | ↑ Buy | 32,534 | $0.27 | $9K | Direct | May 17, 2023 (1d) |
| May 15, 2023 | AMPE | ↑ Buy | 67,466 | $0.24 | $16K | Direct | May 16, 2023 (1d) |
| Mar 26, 2015 | TLOG | ↑ Buy | 5,000 | $4.23 | $21K | Direct | Mar 30, 2015 (4d) |
| Jan 7, 2015 | TLOG | ↑ Buy | 5,000 | $5.04 | $25K | Direct | Jan 9, 2015 (2d) |
| Dec 9, 2014 | TLOG | ↑ Buy | 5,000 | $6.01 | $30K | Direct | Dec 11, 2014 (2d) |
| Dec 2, 2014 | TLOG | ↑ Buy | 10,000 | $4.99 | $50K | Direct | Dec 4, 2014 (2d) |
| Nov 18, 2014 | TLOG | ↑ Buy | 10,000 | $4.82 | $48K | Direct | Nov 20, 2014 (2d) |
| Nov 11, 2014 | TLOG | ↑ Buy | 10,000 | $3.93 | $39K | Direct | Nov 13, 2014 (2d) |
| Dec 17, 2013 | TLOG | ↑ Buy | 285,714 | $7.00 | $2.0M | Direct | Dec 19, 2013 (2d) |
| Jan 29, 2013 | STML | ↑ Buy | 500 | $10.00 | $5K | Direct | Jan 30, 2013 (1d) |
| Mar 5, 2010 | CEPH | ↓ Sell | 30,000 | $70.64 | $2.1M | Direct | Mar 9, 2010 (4d) |
| Dec 3, 2008 | CEPH | ↓ Sell | 15,000 | $74.28 | $1.1M | Direct | Dec 4, 2008 (1d) |
| Dec 6, 2007 | CEPH | ↓ Sell | 20,000 | $76.00 | $1.5M | Direct | Dec 7, 2007 (1d) |
| Feb 17, 2006 | CEPH | ↓ Sell | 28,684 | $74.40 | $2.1M | Direct | Mar 17, 2010 (1489d) |
| Feb 17, 2006 | CEPH | ↓ Sell | 29,073 | $74.40 | $2.2M | Direct | Feb 22, 2006 (5d) |
| Nov 8, 2005 | CEPH | ↓ Sell | 8,400 | $46.51 | $391K | Direct | Nov 9, 2005 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About J Kevin Buchi's insider trades
J Kevin Buchi is a director at Ampio Pharmaceuticals (AMPE). Since Nov 8, 2005, J has reported 12 open-market purchases worth $2.3M and 6 sales worth $9.4M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (51 filings), shares withheld for taxes (17 filings), option exercises (15 filings), gifts (9 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AMPE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.